Astrana Health (ASTH) Short-term Investments (2016 - 2025)
Astrana Health's Short-term Investments history spans 12 years, with the latest figure at $1.2 million for Q3 2025.
- For Q3 2025, Short-term Investments fell 48.13% year-over-year to $1.2 million; the TTM value through Sep 2025 reached $1.2 million, down 48.13%, while the annual FY2024 figure was $2.4 million, 4.8% down from the prior year.
- Short-term Investments for Q3 2025 was $1.2 million at Astrana Health, down from $2.4 million in the prior quarter.
- Across five years, Short-term Investments topped out at $187.2 million in Q2 2021 and bottomed at $1.2 million in Q3 2025.
- The 5-year median for Short-term Investments is $3.8 million (2023), against an average of $32.7 million.
- The largest annual shift saw Short-term Investments skyrocketed 89100.0% in 2021 before it plummeted 92.74% in 2023.
- A 5-year view of Short-term Investments shows it stood at $28.4 million in 2021, then crashed by 80.39% to $5.6 million in 2022, then crashed by 55.13% to $2.5 million in 2023, then decreased by 4.8% to $2.4 million in 2024, then tumbled by 48.65% to $1.2 million in 2025.
- Per Business Quant, the three most recent readings for ASTH's Short-term Investments are $1.2 million (Q3 2025), $2.4 million (Q4 2024), and $2.4 million (Q3 2024).